-+ 0.00%
-+ 0.00%
-+ 0.00%

Enliven Therapeutics Chief Scientific Officer Joseph P. Lyssikatos Reports Disposal of Common Shares

Reuters·01/12/2026 22:13:31

Please log in to view news